Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Sensory Neurography and S2PD After Digital Nerve Injury

16 de noviembre de 2026 actualizado por: Cecilia Mellstrand Navarro

Investigation of the Correlation of Sensory Neurography Findings and S2PD Measurements After Digital Nerve Injury

The goal of this clinical comparative cross sectional study, is to investigate neurophysiological findings and S2PD (static two point discrimination test) measurements after digital nerve injury.

The main aim is to find out if there are measurable neurophysiological differences in fingers following digital nerve injury that correlate with discriminative sensory function (S2PD) as experienced by the patient. Secondary aim is to investigate how well neurophysiological measurements predict specific S2PD values in the affected fingers.

Participants with a sutured digital nerve injury will be examined with neurophysiology and S2PD testing. Both injured finger and corresponding uninjured finger on the other hand will be examined, i.e participants will be their own control.

Prior to the study the investigators will perform a test-re-test study on ten participants to ensure that the method is reliable (separate registration)

Descripción general del estudio

Descripción detallada

The aim of this project is to use neurophysiological assessment to gain a better understanding of what is actually measured by S2PD (static two-point discrimination). A neurophysiological examination can objectively measure any remaining function in an injured digital nerve. Using this method, axons responsible for pressure, vibration, and touch that are still able to conduct an action potential, are assessed.

The response can be measured both as the amplitude of the summed action potentials from the nerve's axons and as the area, which corresponds to the area under the curve formed by the recorded action potentials. The area is a somewhat more precise measurement method, as it includes all axons, both those with low and high conduction velocities. Amplitude measurements may give falsely low values if nerves with poorer degrees of myelination are included in the measurement. Amplitude is measured in µV and area in µV/ms.

The method currently used to assess discriminative sensation, S2PD, is influenced by many external factors, such as the clinician's level of experience, the patient's desire to give the correct answer, language barriers, and similar issues. Furthermore, this examination method does not clarify what is actually being measured beyond the patient's subjective discriminative sensation.

If neurophysiological assessment is used as a complement to S2PD and can provide an objective measurement tool with high reliability and reproducibility, it could become an important addition to the clinical arsenal for follow-up after nerve injury. Such knowledge would make it easier to clinically evaluate, understand, and monitor the healing process of the injured nerve. It would also facilitate the assessment and systematic follow-up of treatment outcomes.

The investigators also believe that patients would benefit from being able to follow nerve healing in a more objective manner, which could help motivate continued training and rehabilitation (such as tactile stimulation, mirror therapy, desensitization, etc.).

Participants will be identified through the national quality register for hand surgery (HAKIR), and will be invited to attend an examination at the Hand Surgery Outpatient Clinic at Sodersjukhuset by phone (postal invitation if no response). If the response rate is low, patients will be contacted by phone one additional time.

The visit, which is estimated to last approximately 60 minutes, will include assessment using static two-point discrimination (S2PD) and neurophysiological examination of the injured finger as well as the corresponding finger on the contralateral, uninjured hand. Sensory assessment with S2PD will be performed on the fingertip pulp, radially or ulnarly, using a discriminator. Sensory thresholds, measured in millimetres, will be recorded in the study protocol.

Finger temperature will be measured using an infrared thermometer (Testo 826-T2), and, if necessary, the fingers will be warmed (using a water bath or heating pad) to a target temperature of a minimum of 32 °C. The hands will then be gently abraded using a preparation gel (NuPrep). Conductive gel (Ten20) will be applied to the electrodes.

A recording electrode will be placed volarly over the wrist, a ground electrode in the palm, and a stimulating electrode on the finger (digits II, III, or IV). Electrical stimulation will be delivered in an orthodromic direction, from the finger toward the wrist. The stimulus intensity will be gradually increased as long as the recorded amplitude continues to rise, up to a maximum of 20% above the intensity at which no further increase in amplitude is observed. This approach ensures inclusion of all excitable axons in the recording, regardless of individual firing thresholds.

Tipo de estudio

De observación

Inscripción (Estimado)

60

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

      • Stockholm, Suecia, 11883
    • Stockholm County
      • Stockholm, Stockholm County, Suecia, 11883
        • Aún no reclutando
        • Karolinska Institutet Södersjukhuset, Department of clinical research and education

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

20 años a 60 años (Adulto)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Patients treated surgically for a digital nerve injury at the Sodersjukhuset Hand Surgery Clinic from 2013 to 2023.

Descripción

Inclusion Criteria:

  • Injury: One year or more prior to inclusion
  • Injured finger: digit II, III or radial dig IV
  • Level of injury: base or middle phalanx
  • Age at injury>20
  • Age at inclusion<60

Exclusion Criteria:

  • Neurologic disease
  • Dementia
  • Cognitive disability
  • Severe psychiatric disorder (not be able to participate)
  • Ongoing drug abuse
  • Not understanding swedish language
  • History of ongoing carpal tunnel syndrome
  • Negative experience of electric stimulation

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: CASE_CONTROL
  • Perspectivas temporales: CROSS_SECTIONAL

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Sensory and neurophysiology outcome in injured digit

The finger with an injured digital nerve will be examined with S2PD and sensory neurography

Participants will be examined with sensory neurography (orthodromic stimulation).

Participants will be examined with S2PD.

Sensory and neurophysiology outcome in normal digit

The contralateral uninjured finger will be examined with S2PD and sensory neurography

Participants will be examined with sensory neurography (orthodromic stimulation).

Participants will be examined with S2PD.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Is there a correlation between the amplitude of the sensory nerve action potential and S2PD?
Periodo de tiempo: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A potential correlation between the sensory nerve action potential amplitude (microvoltage) measured with sensory neurography and S2PD (in millimeters) measured with a discriminator, will be analysed with test for correlation and presented as a value between -1 and 1

Participant assessments will be conducted during a single session lasting approximately 60 minutes
Is there a correlation between sensory nerve action potential area and S2PD?
Periodo de tiempo: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A potential correlation between the sensory nerve action potential area (milliseconds*microvoltage) measured with sensory neurography and S2PD (in millimeters) measured with a discriminator, will be analysed with test for correlation and presented as a value between -1 and 1

Participant assessments will be conducted during a single session lasting approximately 60 minutes

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Does a certain value of S2PD correspond to a specific (percentage) value of the amplitude or area of the action potential?
Periodo de tiempo: Participant assessments will be conducted during a single session lasting approximately 60 minutes

We will evaluate the correlation between S2PD (in 1 mm steps) and the percentages of sensory neurography amplitude and area of the injured nerve.

Participant assessments will be conducted during a single session lasting approximately 60 minutes
How does age affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?
Periodo de tiempo: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A regression analysis will be used to evaluate what impact age (years) has on primary outcomes.

Participant assessments will be conducted during a single session lasting approximately 60 minutes
How does participants' sex affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?
Periodo de tiempo: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A regression analysis will be used to evaluate what impact participants' sex (male or female) has on primary outcomes.

Participant assessments will be conducted during a single session lasting approximately 60 minutes
How does smoking affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?
Periodo de tiempo: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A regression analysis will be used to evaluate what impact smoking (yes or no) has on primary outcomes.

Participant assessments will be conducted during a single session lasting approximately 60 minutes
How does the type of injured nerve affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?
Periodo de tiempo: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A regression analysis will be used to evaluate what impact type of injured nerve (digital nerves to second, third or radial side of the fourth finger) has on primary outcomes.

Participant assessments will be conducted during a single session lasting approximately 60 minutes
How does time from injury affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?
Periodo de tiempo: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A regression analysis will be used to evaluate what impact time from injury (in years) has on primary outcomes.

Participant assessments will be conducted during a single session lasting approximately 60 minutes
How does the level of injury affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD?
Periodo de tiempo: Participant assessments will be conducted during a single session lasting approximately 60 minutes

A regression analysis will be used to evaluate what impact level of injury (proximal or middle phalanx) has on primary outcomes.

Participant assessments will be conducted during a single session lasting approximately 60 minutes

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Cecilia Mellstrand-Navarro, Ass. prof, Karolinska Institutet Södersjukhuset, Department of clinical research and education

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

28 de septiembre de 2026

Finalización primaria (Estimado)

31 de diciembre de 2026

Finalización del estudio (Estimado)

31 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

9 de octubre de 2026

Primero enviado que cumplió con los criterios de control de calidad

23 de octubre de 2026

Publicado por primera vez (Actual)

29 de octubre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

16 de noviembre de 2026

Última verificación

1 de octubre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 2023-05732-01
  • 2023 (Subvención/contrato del NIH de EE. UU.)

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Data will be available in pseudonymized form

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir